Marc A. Schneider , Nicolas C. Kahn , Michael Thomas , Felix J.F. Herth , Thomas Muley , Claus P. Heussel , Michael Meister , Hendrik Dienemann
{"title":"妊娠相关蛋白糖蛋白作为男性非小细胞肺癌患者的随访生物标志物","authors":"Marc A. Schneider , Nicolas C. Kahn , Michael Thomas , Felix J.F. Herth , Thomas Muley , Claus P. Heussel , Michael Meister , Hendrik Dienemann","doi":"10.1016/j.ctrc.2015.09.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Glycodelin is an immunomodulatory protein with high impact during the establishment of pregnancy and implantation of the trophoblast. In recent years, studies have demonstrated that glycodelin is expressed in different tumor entities. Here we show a case report of a male NSCLC patient with a high glycodelin gene (<em>PAEP</em>) and protein expression in the tumor and the serum.</p></div><div><h3>Materials and methods</h3><p>The qPCR data, immunohistochemical stainings of glycodelin in the primary tumor and the metastasis as well as the measurements of glycodelin in the serum were connected and analyzed with the clinical and pathological data of the patient.</p></div><div><h3>Results</h3><p>CT scans of the patient revealed temporarily unclear infiltrations of the lung. The primary tumor of this patient highly expressed the glycodelin gene product (<em>PAEP</em>) as well as the glycodelin protein. Moreover, glycodelin was secreted into the blood and the concentration correlated with the patient's follow-up.</p></div><div><h3>Conclusions</h3><p>With this case report of a male patient we demonstrate that the pregnancy associated protein glycodelin might be a useful biomarker to monitor disease progression in NSCLC patients.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.09.005","citationCount":"2","resultStr":"{\"title\":\"The pregnancy associated protein glycodelin as a follow-up biomarker in a male non-small cell lung cancer patient\",\"authors\":\"Marc A. Schneider , Nicolas C. Kahn , Michael Thomas , Felix J.F. Herth , Thomas Muley , Claus P. Heussel , Michael Meister , Hendrik Dienemann\",\"doi\":\"10.1016/j.ctrc.2015.09.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Glycodelin is an immunomodulatory protein with high impact during the establishment of pregnancy and implantation of the trophoblast. In recent years, studies have demonstrated that glycodelin is expressed in different tumor entities. Here we show a case report of a male NSCLC patient with a high glycodelin gene (<em>PAEP</em>) and protein expression in the tumor and the serum.</p></div><div><h3>Materials and methods</h3><p>The qPCR data, immunohistochemical stainings of glycodelin in the primary tumor and the metastasis as well as the measurements of glycodelin in the serum were connected and analyzed with the clinical and pathological data of the patient.</p></div><div><h3>Results</h3><p>CT scans of the patient revealed temporarily unclear infiltrations of the lung. The primary tumor of this patient highly expressed the glycodelin gene product (<em>PAEP</em>) as well as the glycodelin protein. Moreover, glycodelin was secreted into the blood and the concentration correlated with the patient's follow-up.</p></div><div><h3>Conclusions</h3><p>With this case report of a male patient we demonstrate that the pregnancy associated protein glycodelin might be a useful biomarker to monitor disease progression in NSCLC patients.</p></div>\",\"PeriodicalId\":90461,\"journal\":{\"name\":\"Cancer treatment communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.09.005\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213089615300141\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089615300141","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The pregnancy associated protein glycodelin as a follow-up biomarker in a male non-small cell lung cancer patient
Objectives
Glycodelin is an immunomodulatory protein with high impact during the establishment of pregnancy and implantation of the trophoblast. In recent years, studies have demonstrated that glycodelin is expressed in different tumor entities. Here we show a case report of a male NSCLC patient with a high glycodelin gene (PAEP) and protein expression in the tumor and the serum.
Materials and methods
The qPCR data, immunohistochemical stainings of glycodelin in the primary tumor and the metastasis as well as the measurements of glycodelin in the serum were connected and analyzed with the clinical and pathological data of the patient.
Results
CT scans of the patient revealed temporarily unclear infiltrations of the lung. The primary tumor of this patient highly expressed the glycodelin gene product (PAEP) as well as the glycodelin protein. Moreover, glycodelin was secreted into the blood and the concentration correlated with the patient's follow-up.
Conclusions
With this case report of a male patient we demonstrate that the pregnancy associated protein glycodelin might be a useful biomarker to monitor disease progression in NSCLC patients.